Immuno-Biological Laboratories Co., Ltd.
Immuno-Biological Laboratories Co., Ltd. (4570.T) Stock Overview
Explore Immuno-Biological Laboratories Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
4.7B
P/E Ratio
18.88
EPS (TTM)
$26.75
ROE
0.18%
4570.T Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Immuno-Biological Laboratories Co., Ltd. (4570.T) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 51.11, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $426.16.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.88 and a market capitalization of 4.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.